Personalized Treatment of PLA2R-Related Membranous Nephropathy
Clin J Am Soc Nephrol
.
2023 Apr 1;18(4):530-532.
doi: 10.2215/CJN.0000000000000086.
Epub 2023 Jan 27.
Authors
Gema Fernández-Juárez
1
,
Pierre Ronco
2
3
,
Vivekanand Jha
4
5
6
Affiliations
1
Department of Nephrology, Instituto de Investigación de la Paz (IdIPAZ), Hospital Universitario La Paz, Madrid, Spain.
2
Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche S 1155, Sorbonne Université, Paris, France.
3
Department of Nephrology, Centre Hospitalier du Mans, Le Mans, France.
4
George Institute for Global Health, New Delhi, India.
5
School of Public Health, Imperial College, London, United Kingdom.
6
Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal, India.
PMID:
36747312
PMCID:
PMC10103204
DOI:
10.2215/CJN.0000000000000086
No abstract available
MeSH terms
Autoantibodies
Glomerulonephritis, Membranous* / drug therapy
Humans
Precision Medicine
Receptors, Phospholipase A2
Substances
Autoantibodies
Receptors, Phospholipase A2